Aggregation States of α-Synuclein and Its Involvement in Parkinson’s Disease

WANG Dan-Chen,YU Shan-Shan,LIU Wei-Feng,CHEN Guan-Jun
DOI: https://doi.org/10.3969/j.issn.1007-7626.2006.08.004
2006-01-01
Abstract:Parkinson's disease(PD) is a wide-spread age-related neurodegeneration disorder with very complex pathological mechanisms. α-Synuclein gene is among the first genes identified to be related to PD and the α-synuclein protein is a major component of protein inclusions called Lewy bodies, whose appearance in the survival dopamine neurons is one of the pathologic hallmarks of PD.α-synuclein has recently been shown to undergo transitions between different aggregation states both in vivo and in vitro, mediated by the readily aggregated propensity of α-synuclein. Among others, an intermediate oligomer configuration called protofibril, has been found to show much stronger cytotoxicity than the insoluble fibril conformation, which is the final form of polymerization normally found in Lewy bodies. In the meantime, quite a few genetic and cellular factors including α-synuclein gene mutation and duplication, lipid metabolism, oxidative stress as well as protein folding and quality control system, have been demonstrated to affect the process of α-synuclein aggregation. These findings are beginning to uncover the underlying mechanisms of the occurrence and development of PD. Herein, we review recent findings on the structural characterization of α-synuclein and exploit the possible molecular and cellular mechanisms involved in the etiopathogenesis of PD.
What problem does this paper attempt to address?